The protective effect of cilostazol on experimental ischemia/reperfusion injury in rats ovaries on in vitro fertilization outcomes
article
OA: gold
CC0
Abstract
Objective: Ovarian torsion decreases ovarian reserve because of ischemic and reperfusion damage it causes. In this study, we investigated the protective effect of cilostazol (CIL) on experimental ischemia (I) and ischemic-reperfusion (I/R) damage in rat ovaries with in vitro fertilization (IVF) results. Materials and Methods: Forty-eight adult female Sprague-Dawley albino rats were randomly assigned to 6 groups with 8 animals in each group: Sham (S), I, I/R, S + CIL, I + CIL and I/R + CIL. The I groups were subjected to bilateral adnexal torsion for 3 h, while the I/R and I/R + CIL groups received subsequent detorsion for 3 h. Twenty-two mg/kg of CIL was given via oral gavage 30 min before surgery on the I (I+ CIL) or reperfusion (I/R + CIL) groups. Oocytes were collected before the IVF procedure and after ovulation induction with 150-300 IU/kg pregnant mare serum gonadotropin. Results: The metaphase oocytes reached their highest value of 4.73±0.96 in the S+ CIL group and reached their lowest value of 0.51±0.55 in the I/R group. There were statistically significant differences in the number of second-day embryos among the I, I+ CIL, and I/R and I/R+ CIL groups (p=0.000). When the groups were compared in terms of Anti-Müllerian hormone change, the highest decrease was observed in the I and I/R groups. Conclusion: CIL pretreatment before surgery has a protective effect against I and I/R in rats with ovarian torsion.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (29)
- doi:10.1148/rg.273065116 via openalex
- doi:10.1067/mem.2001.114303 via openalex
- doi:10.1161/strokeaha.119.026655 via openalex
- doi:10.1080/01443615.2019.1701639 via openalex
- doi:10.1152/ajpcell.00112.2001 via openalex
- doi:10.1159/000489241 via openalex
- doi:10.1007/s00404-015-3878-8 via openalex
- doi:10.1016/j.ejogrb.2004.05.007 via openalex
- W4089902 via openalex
- W49614849 via openalex
- doi:10.1016/j.ejvs.2008.11.028 via openalex
- doi:10.1016/j.tjog.2020.10.004 via openalex
- doi:10.1111/jcmm.13330 via openalex
- doi:10.1159/000360811 via openalex
- doi:10.1590/s0102-86502012001100007 via openalex
- doi:10.1063/1.2192348 via openalex
- doi:10.1016/j.jmig.2013.09.010 via openalex
- doi:10.1007/bf01395323 via openalex
- doi:10.3906/sag-1803-196 via openalex
- doi:10.1532/hsf.1663 via openalex
- doi:10.1016/0890-6238(96)00028-7 via openalex
- doi:10.37434/tpwj2020.05.02 via openalex
- doi:10.1016/j.etp.2016.01.002 via openalex
- doi:10.1095/biolreprod40.6.1257 via openalex
- doi:10.1177/1538574420953944 via openalex
- doi:10.1016/j.theriogenology.2020.01.006 via openalex
- doi:10.37434/as2021.05.06 via openalex
- doi:10.1007/s00404-020-05934-3 via openalex
- doi:10.1080/01443615.2020.1816938 via openalex
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-05-14T06:04:04.317202+00:00
License: CC0
· commercial use OK